复杂心脏异常的新生儿姑息治疗:大型三级心脏中心跨学科项目十年经验
该研究报告了纽约-长老会摩根士丹利儿童医院/哥伦比亚大学医学中心新生儿舒适护理项目2008至2017年的结局:共照护75名胎儿或新生儿,包括29例孤立性单心室先天性心脏病、36例先心病合并多器官功能障碍和/或严重遗传异常,以及10例产前诊断孤立性先心病但出生后确诊严重疾病者。
要点
- 孤立性单心室先心病父母中13.5%选择新生儿姑息治疗。
- 2例混合病变存活至3岁和5岁,1例后来转向手术姑息。
核心结论
- 新生儿姑息治疗是单心室先心病新生儿的一种合理选择。
研究设计与样本
- 回顾性报告纽约-长老会摩根士丹利儿童医院/哥伦比亚大学医学中心新生儿舒适护理项目2008至2017年照护的75名胎儿或新生儿。
- 该项目为跨学科团队,向产前诊断生命受限疾病的新生儿提供姑息治疗选项。
主要发现
- 75名胎儿或新生儿中,29例为孤立性单心室先心病,36例为先心病合并多器官功能障碍和/或严重遗传异常,10例为产前诊断孤立性先心病但出生后确诊严重疾病。
- 29例孤立性单心室先心病中13.5%的父母选择新生儿姑息治疗。
- 2例混合病变新生儿存活至3岁和5岁,1例先接受姑息治疗后来转向手术姑息。
- 10例产前诊断孤立性先心病但出生后确诊严重疾病的新生儿最初在重症监护室治疗,后因预后不良转向姑息治疗。
临床怎么用
- 对于产前诊断单心室先心病或先心病合并多器官功能障碍/严重遗传异常的新生儿,可向家庭提供新生儿姑息治疗选项。
- 新生儿姑息治疗可作为单心室先心病新生儿的一种合理选择。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To report the outcomes of a Neonatal Palliative Care (NPC) Program at a large tertiary cardiac center caring for a subset of fetuses and neonates with life-limiting cardiac diagnoses or cardiac diagnoses with medical comorbidities leading to adverse prognoses. STUDY DESIGN: The Neonatal Comfort Care Program at New York-Presbyterian Morgan Stanley Children's Hospital/Columbia University Medical Center is an interdisciplinary team that offers the option of NPC to neonates prenatally diagnosed with life-limiting conditions, including single ventricle (SV) congenital heart disease (CHD) or less severe forms of CHD complicated by multiorgan dysfunction or genetic syndromes. RESULTS: From 2008 to 2017, the Neonatal Comfort Care Program cared for 75 fetuses or neonates including 29 with isolated SV CHD, 36 with CHD and multiorgan dysfunction and/or severe genetic abnormalities, and 10 neonates with a prenatal diagnosis of isolated CHD and postnatal diagnoses of severe conditions who were initially in intensive care before transitioning to NPC because of a poor prognosis. CONCLUSIONS: At New York-Presbyterian Morgan Stanley Children's Hospital/Columbia University Medical Center, a large tertiary cardiac center, 13.5% of parents of fetuses or neonates with isolated SV CHD opted for NPC. Twenty-six of 29 newborns with SV CHD treated with NPC died. Of the remaining, 2 neonates with mixing lesions are alive at 3 and 5 years of age, and 1 neonate was initially treated with NPC and then pursued surgical palliation. These results suggest that NPC is a reasonable choice for neonates with SV CHD.
引用
- Haxel C, Glickstein J, Parravicini E, et al. Neonatal Palliative Care for Complicated Cardiac Anomalies: A 10-Year Experience of an Interdisciplinary Program at a Large Tertiary Cardiac Center. J Pediatr. 2019. PMID: 31655705. doi:10.1016/j.jpeds.2019.07.044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。